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Introduction
Search for the source of the pluripotent stem cells
(PSC) capable of prducing the tissues of various kinds
has been seriously withheld when it became apparent
that the only known efficient source of such cells in
humans can be found in the embryos. This has clearly
set the ethical barrier, which delayed further studies on
the PSC, as well as aroused serious concerns for poten-
tial use of these cells in medical practice.
Until know the available evidence suggested that
the cells possessing pluripotent potential, able to
regenerate various tissues, could be found in non-
embryonic tissues like the BM or UCB [1-7]. Recent-
ly a population of the very small embryonic-like
(VSEL) stem cells was isolated from the adult murine
BM [8] as well as from the other adult tissues [9-10].
VSEL were sorted from the BM as a population of
small Sca-1+lin-CD45- cells that express also CXCR4
receptor [8]. It was confirmed, that these cells express
markers characteristic of embryonic PSC, like SSEA-
1, Oct-4, Nanog and Rex-1, as well as they differenti-
ate in vitro into cells from all three germ layers [8].
This discovery gave a new impulse to the researches in
adult stem cells and their potential application in
regenerative medicine [11].
The identification of VSEL in mice prompted us to
search for a similar population of stem cells in
humans. Since UCB had been described as a potential
source of primitive stem cells [12-14], we employed
an analogical strategy as for the murine BM to sort
these cells from human UCB. Based on our experience
with purifying VSEL from murine tissues, we assumed
that similarly as in mice, human VSEL will be also
very small in size [8].
Using the technique based on the novel two-step
procedure (1st step - removal of the erythrocytes from
the sample by hypotonic ammonium chloride lysis,
and the 2nd step - multiparameter high speed sorting)
we successfully isolated VSEL stem cells from the
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UCB. Here this procedure is described in details with
the possible technical problems that have to be solved
for successful VSEL stem cell isolation.
Materials and methods
UCB collection. The UCB was obtained from the umbilical cords
and placenta after the delivery of placenta and maximum attention
has been paid to aseptic procedures. The UCB was harvested to the
containers and mixed with anticoagulant (heparin - 2500 I.U. per
ml of UCB). The usual amount of blood harvested from one umbil-
ical cord ranged between 10 and 60 ml. The blood was then stored
at 4°C for up to two days before further processing. To increase the
volume of the sorted UCB, usually two independently obtained
samples were combined.
Hypotonic removal of erythrocytes. The UCB was then mixed
with NH4Cl based BD Pharm Lyse lysing buffer (BD Biosciences,
San Jose, CA, USA) for 15 min at room temperature and washed
twice in phosphate-buffered saline (PBS). This step was repeated
up to three times, depending on the efficiency of lysis.
FACS-based sorting of VSEL. Next, 1-3×108 of UCB MNC were
stained with monoclonal antibodies. For linage markers we used
antibodies against: CD2 clone RPA-2.10, CD3 clone SK7, CD14
clone MϕP9, CD16 clone 3G8, CD19 clone HIB19, CD24 clone
ML5, CD56 clone NCAM16.2, CD66b clone G10F5, CD235a clone
GA-R2. All the linage markers directed antibodies were conjugated
with fluorescein isothiocyanate (FITC). The anti-CD45 (clone
H130) was conjugated with phycoerythrin (PE), and antibodies
against CXCR4 (clone 12G5), CD34 (clone 581) and CD133 (clone
CD133/1) (Miltenyi Biotec GmbH) were all conjugated with allo-
phycocyanin (APC). The antibodies were provided by BD Pharmin-
gen, San Jose, CA, USA, except otherwise specified. The samples
were incubated with antibodies at room temperature for 30 min.
After being washed, the cells were run through the 40 μm gauge fil-
ters (BD Falcon, San Jose, CA, USA) to remove potential clots. The
final sample concentration was 2-8x107cells/ml of PBS.
The sort was performed on the FACSAria instrument (BD, San
Jose, CA, USA) utilizing the high speed sorting settings with the
use of 70 μm nozzle. The basic principles of gating for sort the
were: i) the P1 gate on the SSC/FSC dot plot was set on the lym-
phocyte region with the inclusion of very small cells, ii) the P1
restricted P2 gate on the FITC/APC dot plot was set the way that
only non-lineage markers expressing cells and the APC conjugat-
ed antibodies positive cells (CXCR4+ or CD34+ or CD133+) were
included, iii) the P2 restricted P3 gate on the SSC/PE dot plot was
set to include only the CD45 negative cells. The cells were col-
lected to the tube coated with 10% FBS.
General outline of the experiment is presented in Fig. 1. The
data presented in the paper are based on the sorts performed on 28
UCB samples. 
Results and discussion
By employing FACS analysis it was found that cells
expressing the potential VSEL phenotype (CXCR4+
lin-CD45-, CD34+lin-CD45- and CD133+lin-CD45-)
are very rare and could be found in the human UCB
with the following rates respectively: 0037%±0.02
n=9, 0.118%±0.028 n=5 and 0.018%± n=9 (9). Thus,
based on a very low frequency of these cells in order
to isolate them from UCB we decided to avoid
immunomagnetic beads isolation as a potentially less
efficient method and employed FACS-based multi-
parameter sorting.
However, the choice of high speed FACS sorting as
an isolation method of VSEL required elimination of
the erythrocytes from the samples before UCB MNC
could be run on the sorter. Since the removal of red
blood cells (RBC) by centrifugation over Ficoll-Paque
gradient might lead to the loss of the VSEL stem cells
from UCB samples due to their very small size and
possibility of being engulfed by sedimenting RBCs,
we employed hypotonic ammonium chloride solution
to lyse RBC. When necessary, this lysis procedure had
to be repeated up to two-three times.
The removal of erythrocytes from the UCB sam-
ples prepared for sorting turned out to be crucial, as
their presence in the P1 gate on SSC/FSC dot plot
overlapped with the cytogram of the VSEL stem cells
which are located close to the lymphocyte region (Fig.
2). As it is shown in Fig. 2 because of the small cell
size of the VSEL we had to move the sorting gate to
the left to the area that contains RBCs and cell debris.
Fig. 3 shows a dot plot containing cells from the P1
gate, which was set to include cells that are hematopoi-
etic lineages negative (all anti-lineage antibodies were
conjugated with FITC), and express either CXCR4 or
CD34 or CD133 antigens. In several experiments we
alternatively stained aliquots of the same sample indi-
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Fig. 1.  Outline of the experiment. One
to two UCB samples were first lysed
with the lysing buffer, then stained with
the appropriate antibodies, and finally
07-3×108 cells were run on the FACS
Aria sorter.
vidually with each of these three markers and were
able to isolate VSEL, although in some of these
attempts the CD133 use has given markedly smaller
number of sorted cells from the same sample.
Fig. 4 shows a dot plot, where the CD45 expression
was analyzed against the SSC, to gate the CD45 nega-
tive cells from those present in the gates P1 and P2.
This step was crucial to exclude potential hematopoi-
etic stem cells from the sorted cell population.
There were certain issues, however, that we had to
consider in setting up our sorting strategy. First, it was
important to assess how restrictive the gating should
be in order to allow for high enrichment of VSEL.
When the subpopulations of the cells abundantly rep-
resented in the sample are sorted, the settings of the
sort can be as restrictive as it is needed, to harvest the
highly purified population of cells. However, our goal
to sort the relatively rare cells such as lin-CD45-
CXCR4+, lin-CD45-CD34+ or lin-CD45-CD133+
UCB MNC, which could be found in the UCB samples
with frequencies between approximately 1 in 1×104 -
1×105, forced us to the lower requirements for their
final purity. Thus, we employed gating which was
somehow wider from usually employed, and in addi-
tion, the instrument internal sort purity control settings
were set to allow maximum yield of VSEL on expense
of their purity. This was acceptable, since our final
goal was not to purify the VSEL, but to enrich the
material in these cells. Because there is no specific
marker for these cells exclusively available yet, FACS
based purification of these cells is very difficult at this
point. The high enrichment for VSEL, however, was
achieved as confirmed subsequently in the variety of
tests performed with these cells [9].
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Fig. 2.  Gating on the SSC/FSC dot plot was one of the most
important steps in the sort setup. The threshold set on FSC has to
be set very low, even despite some RBCs remnants/debris
obstructing the view.  The VSEL on this plot are located far from
the main population of lymphocytes, thus the P1 gate has to be
extended to the left towards small events.
Fig. 3.  Events on this dot plot are restricted to those present in the
P1 gate on SSC/FSC plot. The position and the extent of the gate
P2 were set based on the negative isotype control values, but P2
gate was also designed to sort cells based on subjective judgment.
Fig. 4. The events shown on this dot plot were all located within
the P2 gate on CXCR4/Lin dot plot. In the gate P4 two subpopu-
lations of CD45 positive cells (bright and dim) are visible. P3 gate
contains VSEL stem cells and it is the gate designed for sorting.
Another pitfall was to determine the maximum
speed that could be safely applied. Although the
FACSAria instrument, on which sorts were performed,
is designed to enable sorting with the maximum speed
of up to 70 thousand events per second, the initial sorts
were done at the speed of 8 thousand events per sec-
ond. Then, after the confirmation that the sorted mate-
rial is enriched for VSEL, we decided to increase the
speed up to ~20 thousand events per second. We
noticed that above this limit, the frequency of cells lost
from the sort due to the electronic abort, applied by the
instrument to the events which do not meet the number
of preset requirements, increased markedly.
The usual sorting time of typical sample of 1-3×108
MNCs from UCB was between 0.5 and 3 hours, and
depended on the speed of the sorting and the potential
sample clotting. The occurrence of the clotting differed
from sample to sample and required interruption of the
sort and filtering of the cells. Sometimes this had to be
repeated several times (up to × 4) during one sort.
Although the one stage sorting procedure was per-
formed for most of the times and enabled us to sort
large number of VSEL, we also tested two step sorting.
In the first step in this latter strategy we sorted lineage
negative cells versus CD45 antigen, and next such
cells were stained with antibodies against CXCR4,
CD34 or CD133 and sorted while expressing these
markers. However, it turned out that recovery of VSEL
was several fold lower then in one stage sort (the
results of tests with two step procedure not shown).
The number of cells sorted from the typical 1-3
×108 MNC sample of UCB, was between few hundred
to 50 thousand. It is impossible to established any reli-
able statistical analyses regarding this parameter,
because of the numerous factors including i) the fact
that the UCB samples were combined from various
deliveries in unknown proportions, ii) the gating and
the purity settings were arranged in unrestrictive man-
ner and differed from sort to sort, iii) the speed of the
sort varied in individual sorts, and finally, iv) the num-
ber of clotting events and related to this filtering of the
samples (which may lead to the loss of cells) was also
different for each sort. The selected examples of the
sorted sample size and the sort outcome are presented
in Table 1.
The special attention was paid to the antiseptic
conditions of the sort. Although the microbiological
purity of the sorted samples was not tested because of
the limited size of the samples, cells from the selected
sorts were seeded in the culture media and stayed free
of bacterial or fungal overgrowth for 1-2 weeks.
Another important issue was the viability of sorted
cells. The viability tests performed immediately after
the sort revealed that 66-82% of sorted cells were
viable, as assessed by tripan blue exclusion test. 
In conclusion, we were able to successfully enrich
the UCB MNC for the VSEL stem cells and this
enrichment was confirmed by PCR for the expression
of mRNA for PSC markers as well as by the transmis-
sion electron microscope. Further experiments are
required though, to improve the sorting conditions for
the more efficient enrichment of the UCB for these
cells. The identification of VSEL-specific surface
markers would be an important step toward this direc-
tion. It seems that the possibility of isolation of VSEL
from non embryonic tissues is an important step in the
adult stem cell research and gives hope for their clini-
cal application in the near future.
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